bioAffinity Technologies Welcomes New Board Members
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held cancer diagnostics company, will seat two new members on its Board of Directors at the third-quarter meeting Oct. 26, 2015. Company President and Chief Executive Officer Maria Zannes announced that Myron Holubiak and Barry Frankel are joining the Board.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.